Science Sphere

🧬 Your weekly science updates. Read more 👇🏻

Cancer: https://bit.ly/4viowhR
Exercise: https://bit.ly/43578kQ
Pigeon: https://bit.ly/4u4jVyU
Memory: https://bit.ly/4dW1J4z
Neurons: https://bit.ly/4uJ76eD
Peppermint: https://bit.ly/4u4qjG8

This Week in Science (25 May - 31 May 2026)

🧪 Your weekly science updates. Read more 👇🏻

Melanoma: https://bit.ly/3RnNEFn
Dark Matter: https://bit.ly/4wMFt5u
Dementia: https://bit.ly/4dnI8uY
Sugar: https://bit.ly/4uvqCer
DNA: https://bit.ly/4utzfWE
T rex: https://bit.ly/4uWHuKE

This Week in Science (18 May - 24 May 2026)

🔬Your weekly science updates. Read more 👇🏻

Psilocybin: https://bit.ly/42XPsaN
PMOS: https://bit.ly/3ReGUtl
JWST: https://sou42.co/4tAq5q3
Africa: https://bit.ly/49xCLHa
Snacking: https://bit.ly/4nHQnWb
Contacts: https://bit.ly/4tXTs6d

This Week in Science (11 May - 17 May 2026)

🦠 Probiotics are not just “good bacteria” in a bottle.

Most probiotic supplements contain live microbes, often strains of Lactobacillus and Bifidobacterium, in doses that can range from billions to tens of billions of organisms per capsule.

Some strains have evidence for specific uses, such as reducing the risk of antibiotic-associated diarrhea. But the effects are strain-specific, meaning one probiotic cannot be assumed to do what another does.

For most healthy people, probiotics are generally safe, but they are not risk-free. In people with weakened immune systems, serious illness, premature infants, or central lines, live bacteria can rarely cause dangerous infections.

The bigger issue is marketing. Many products make vague “gut health” claims without proving that their exact strains, dose, and formulation deliver meaningful benefits.

For everyday gut health, fiber-rich foods, diverse plants, and fermented foods often matter more than expensive capsules.

📃 RESEARCH PAPER
📌 Sanders et al., “Probiotics and prebiotics in intestinal health and disease: from biology to the clinic”, Nature Reviews Gastroenterology & Hepatology (2019)

🫀 Severe obesity may weaken the heart muscle at the cellular level — but weight loss may help restore some of that function.

A new study focused on people with heart failure with preserved ejection fraction, or HFpEF. In this condition, the heart can still pump normally, but it does not fill properly, often because the heart muscle becomes stiff.

Researchers analyzed heart muscle cells from 80 people with obesity and HFpEF. Cells from those with more severe obesity had a much weaker ability to increase contraction force, resembling patterns seen in advanced heart failure.

The team traced part of this weakness to chemical changes in troponin-I, a protein that helps heart muscle contract and relax.

Importantly, people who lost weight with GLP-1 treatment showed improved heart muscle contraction, suggesting some obesity-related heart damage may be reversible. The findings are early, but they offer a more hopeful view of obesity-linked heart failure.

📃 RESEARCH PAPER
📌 Jani et al., “Severe obesity in human HFpEF alters contractile protein function and organization”, Science (2026)

🩸 A hidden blood-fat particle may explain why some people remain at heart risk even after treatment.

Lipoprotein(a), or Lp(a), is a cholesterol-carrying particle that is mostly shaped by genetics. Unlike LDL cholesterol, it is not usually measured in a standard lipid test, and lifestyle changes have little effect on its level.

In a new analysis of 20,070 adults from three NIH trials, people with very high Lp(a) — 175 nmol/L or above — had a higher risk of major cardiovascular events over nearly 4 years, especially stroke and cardiovascular death. The link was strongest in people who already had cardiovascular disease.

This does not mean Lp(a) predicts every heart event; the study found no clear link with heart attack risk. But it supports the idea that a one-time Lp(a) blood test could help identify hidden cardiovascular risk.

📃 RESEARCH PAPER
📌 Banerjee, “Lipoprotein(a) identifies residual cardiovascular risk in NIH randomized trials”, SCAI Scientific Sessions (2026)

🍟 French fries may raise diabetes risk in a way other potatoes do not.

A large study followed more than 205,000 U.S. health professionals for nearly 40 years. During that time, 22,299 participants developed type 2 diabetes.

After adjusting for lifestyle and diet factors, researchers found that every three weekly servings of French fries were linked to a 20% higher rate of type 2 diabetes. But similar amounts of boiled, baked, or mashed potatoes were not linked to a substantially higher risk.

The study also found that replacing potatoes with whole grains was associated with lower diabetes risk, while replacing them with white rice was linked to higher risk.

This does not prove that French fries directly cause diabetes. But it suggests preparation method matters — and that the food replacing potatoes matters too.

📃 RESEARCH PAPER
📌 Mousavi et al., “Total and specific potato intake and risk of type 2 diabetes: results from three US cohort studies and a substitution meta-analysis of prospective cohorts”, BMJ (2025)

🫀 During pregnancy, a fetus may quietly help heal its mother’s injured heart.

In a groundbreaking study, researchers at the Mount Sinai School of Medicine discovered that fetal stem cells from the placenta can travel into the mother’s body and repair damaged heart tissue after injury.

Using mouse models, the team found that these fetal cells naturally migrated to injured regions of the maternal heart during pregnancy. Once there, they integrated into the tissue and transformed into working heart cells, including smooth muscle cells, blood vessel cells, and cardiomyocytes.

Even more remarkably, in laboratory experiments, the fetal cells began beating spontaneously in culture dishes — behaving like real heart tissue. The findings, presented at the American Heart Association’s Scientific Sessions and published in Circulation Research, represent a major step forward in regenerative heart medicine.

The placenta-derived stem cells — usually discarded after birth — appear capable of specifically targeting damaged heart tissue without provoking immune rejection. Their natural regenerative ability and ethical advantages over embryonic stem cells could make them a promising future therapy not only for heart disease, but potentially for repairing other organs as well.

The discovery highlights the extraordinary biological connection between mother and fetus and may one day reshape how cardiac injuries are treated after pregnancy.

Source: Chaudhry, H., Kara, R., et al. (2011). Circulation Research, American Heart Association Scientific Sessions

🧠 Scientists have directly observed a hidden drainage route in the human brain.

Using advanced real-time MRI, researchers tracked fluid movement along the middle meningeal artery, a vessel running through the brain’s outer protective layer. In five healthy volunteers scanned over six hours, the fluid moved slowly and steadily — very differently from fast-flowing blood.

The team also studied human brain tissue with ultra-high-resolution imaging and found lymphatic-like structures around the same artery. Together, the findings suggest this region acts as a drainage hub, helping cerebrospinal and interstitial fluids move waste away from the brain.

This does not mean a new Alzheimer’s treatment is ready. But because brain waste clearance is thought to matter in aging, injury, and neurodegenerative disease, mapping this pathway in healthy humans could help scientists understand what goes wrong in disease.

📃 RESEARCH PAPER
📌 Albayram et al., “Meningeal lymphatic architecture and drainage dynamics surrounding the human middle meningeal artery”, iScience (2025)

🧠 Scientists may have found a brain circuit that helps pain become chronic.

In animal experiments, researchers focused on a small region deep in the brain called the caudal granular insular cortex, or CGIC. This area appears to help decide whether short-term pain fades normally or stays active long after an injury.

The team found that the CGIC sends signals to the somatosensory cortex, which then communicates with the spinal cord to keep touch-and-pain signals going. When this pathway was switched off shortly after nerve injury, chronic pain did not develop. When it was silenced after chronic pain had already begun, pain-like sensitivity disappeared in the animals.

This does not mean a human treatment is ready. The study was done in animals, and scientists still need to learn what triggers this pathway. But it points to a possible future target for chronic pain therapies beyond opioids.

📃 RESEARCH PAPER
📌 Ball et al., “Caudal Granular Insular Cortex to Somatosensory Cortex I: A Critical Pathway for the Transition of Acute to Chronic Pain”, The Journal of Neuroscience (2026)